A novel technology for the production of a heterologous lipoprotein immunogen in high yield has implications for the field of vaccine design

Vaccine

Volumn 27, Issue 9, 2009, Pages 1400-1409

  Chen, Hsin Wei ^a   Liu, Shih Jen ^a   Liu, Hsueh Hung ^a   Kwok, Yan ^a   Lin, Chang Ling ^a   Lin, Li Hsiu ^a,b   Chen, Mei Yu ^a   Tsai, Jy Ping ^a   Chang, Li Sheng ^a   Chiu, Fang Feng ^a   Lai, Li wei ^a   Lian, Wei Cheng ^a,c   Yang, Chiou Ying ^a,b   Hsieh, Shih Yang ^a   Chong, Pele ^a   Leng, Chih Hsiang ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c CENTER FOR DISEASE CONTROL   (Taiwan)

Author keywords

Immune responses; Intrinsic adjuvant; Lipoprotien

Indexed keywords

ANTIGEN; LIPOPROTEIN; NEUTRALIZING ANTIBODY; PROTEIN AG473; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

AMINO TERMINAL SEQUENCE; ANTIBODY RESPONSE; ARTICLE; DENGUE VIRUS; DRUG DESIGN; ESCHERICHIA COLI; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TECHNOLOGY; VACCINE PRODUCTION;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; BASE SEQUENCE; CLONING, MOLECULAR; DNA PRIMERS; DRUG DESIGN; ESCHERICHIA COLI; LIPOPROTEINS; MOLECULAR SEQUENCE DATA; NEUTRALIZATION TESTS; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; VACCINES; VACCINES, SYNTHETIC;

EID: 59649116879     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.12.043     Document Type: Article

References (36)

1. Pardoll D.M. Spinning molecular immunology into successful immunotherapy. Nat Rev Immunol 2 4 (2002) 227-238
2. Erdile L.F., Brandt M.A., Warakomski D.J., Westrack G.J., Sadziene A., Barbour A.G., et al. Role of attached lipid in immunogenicity of Borrelia burgdorferi OspA. Infect Immun 61 1 (1993) 81-90
3. Fikrig E., Barthold S.W., Kantor F.S., and Flavell R.A. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science 250 4980 (1990) 553-556
4. Fikrig E., Telford III S.R., Barthold S.W., Kantor F.S., Spielman A., and Flavell R.A. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc Natl Acad Sci USA 89 12 (1992) 5418-5421
5. Parker T.S., Levine D.M., Chang J.C., Laxer J., Coffin C.C., and Rubin A.L. Reconstituted high-density lipoprotein neutralizes gram-negative bacterial lipopolysaccharides in human whole blood. Infect Immun 63 1 (1995) 253-258
6. Philipp M.T., Lobet Y., Bohm Jr. R.P., Roberts E.D., Dennis V.A., Gu Y., et al. The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey. Vaccine 15 17-18 (1997) 1872-1887
7. Johnson B.J., Sviat S.L., Happ C.M., Dunn J.J., Frantz J.C., Mayer L.W., et al. Incomplete protection of hamsters vaccinated with unlipidated OspA from Borrelia burgdorferi infection is associated with low levels of antibody to an epitope defined by mAb LA-2. Vaccine 13 12 (1995) 1086-1094
8. Bockenstedt L.K., Fikrig E., Barthold S.W., Kantor F.S., and Flavell R.A. Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice. J Immunol 151 2 (1993) 900-906
9. Infante-Duarte C., and Kamradt T. Lipopeptides of Borrelia burgdorferi outer surface proteins induce Th1 phenotype development in alphabeta T-cell receptor transgenic mice. Infect Immun 65 10 (1997) 4094-4099
10. Oftung F., Wiker H.G., Deggerdal A., and Mustafa A.S. A novel mycobacterial antigen relevant to cellular immunity belongs to a family of secreted lipoproteins. Scand J Immunol 46 5 (1997) 445-451
11. Brightbill H.D., Libraty D.H., Krutzik S.R., Yang R.B., Belisle J.T., Bleharski J.R., et al. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors. Science 285 5428 (1999) 732-736
12. Thoma-Uszynski S., Stenger S., Takeuchi O., Ochoa M.T., Engele M., Sieling P.A., et al. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291 5508 (2001) 1544-1547
13. Hantke K., and Braun V. Covalent binding of lipid to protein. Diglyceride and amide-linked fatty acid at the N-terminal end of the murein-lipoprotein of the Escherichia coli outer membrane. Eur J Biochem 34 2 (1973) 284-296
14. Rezwan M., Grau T., Tschumi A., and Sander P. Lipoprotein synthesis in mycobacteria. Microbiology 153 Pt 3 (2007) 652-658
15. De B.K., Sampson J.S., Ades E.W., Huebner R.C., Jue D.L., Johnson S.E., et al. Purification and characterization of Streptococcus pneumoniae palmitoylated pneumococcal surface adhesin A expressed in Escherichia coli. Vaccine 18 17 (2000) 1811-1821
16. Legrain M., Speck D., and Jacobs E. Production of lipidated meningococcal transferrin binding protein 2 in Escherichia coli. Protein Expr Purif 6 5 (1995) 570-578
17. Cullen P.A., Lo M., Bulach D.M., Cordwell S.J., and Adler B. Construction and evaluation of a plasmid vector for the expression of recombinant lipoproteins in Escherichia coli. Plasmid 49 1 (2003) 18-29
18. Kamalakkannan S., Murugan V., Jagannadham M.V., Nagaraj R., and Sankaran K. Bacterial lipid modification of proteins for novel protein engineering applications. Protein Eng Des Sel 17 10 (2004) 721-729
19. Hansson L., Noppa L., Nilsson A.K., Stromqvist M., and Bergstrom S. Expression of truncated and full-length forms of the Lyme disease Borrelia outer surface protein A in Escherichia coli. Protein Expr Purif 6 1 (1995) 15-24
20. Madurawe R.D., Chase T.E., Tsao E.I., and Bentley W.E. A recombinant lipoprotein antigen against Lyme disease expressed in E. coli: fermentor operating strategies for improved yield. Biotechnol Prog 16 4 (2000) 571-576
21. Shang E.S., Summers T.A., and Haake D.A. Molecular cloning and sequence analysis of the gene encoding LipL41, a surface-exposed lipoprotein of pathogenic Leptospira species. Infect Immun 64 6 (1996) 2322-2330
22. Dumon-Seignovert L., Cariot G., and Vuillard L. The toxicity of recombinant proteins in Escherichia coli: a comparison of overexpression in BL21 (DE3), C41(DE3), and C43(DE3). Protein Expr Purif 37 1 (2004) 203-206
23. Hsu C.A., Lin W.R., Li J.C., Liu Y.L., Tseng Y.T., Chang C.M., et al. Immunoproteomic identification of the hypothetical protein NMB1468 as a novel lipoprotein ubiquitous in Neisseria meningitidis with vaccine potential. Proteomics 8 10 (2008) 2115-2125
24. Dillon P.J., and Rosen C.A. A rapid method for the construction of synthetic genes using the polymerase chain reaction. Biotechniques 9 3 (1990) 298-300
25. Lutz M.B., Kukutsch N., Ogilvie A.L., Rossner S., Koch F., Romani N., et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223 1 (1999) 77-92
26. von Heijne G. The structure of signal peptides from bacterial lipoproteins. Protein Eng 2 7 (1989) 531-534
27. Hayashi S., and Wu H.C. Lipoproteins in bacteria. J Bioenerg Biomembr 22 3 (1990) 451-471
28. Sankaran K., and Wu H.C. Lipid modification of bacterial prolipoprotein. Transfer of diacylglyceryl moiety from phosphatidylglycerol. J Biol Chem 269 31 (1994) 19701-19706
29. Klotz A.V., and Glazer A.N. gamma-N-methylasparagine in phycobiliproteins. Occurrence, location, and biosynthesis. J Biol Chem 262 36 (1987) 17350-17355
30. Leng CH, Liu SJ, Tsai JP, Li YS, Chen MY, Liu HH, et al. A novel dengue vaccine candidate that induces cross-neutralizing antibodies and memory immunity. Microb Infect (2009), doi:10.1016/j.micinf.2008.12.004.
31. Ozinsky A., Underhill D.M., Fontenot J.D., Hajjar A.M., Smith K.D., Wilson C.B., et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors. Proc Natl Acad Sci USA 97 25 (2000) 13766-13771
32. Takeuchi O., Sato S., Horiuchi T., Hoshino K., Takeda K., Dong Z., et al. Cutting edge: role of Toll-like receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169 1 (2002) 10-14
33. Takeuchi O., Kawai T., Muhlradt P.F., Morr M., Radolf J.D., Zychlinsky A., et al. Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 13 7 (2001) 933-940
34. Cronan Jr. J.E., and Gelmann E.P. Physical properties of membrane lipids: biological relevance and regulation. Bacteriol Rev 39 3 (1975) 232-256
35. Raetz C.R. Enzymology, genetics, and regulation of membrane phospholipid synthesis in Escherichia coli. Microbiol Rev 42 3 (1978) 614-659
36. Schlesinger M.J. Lipid modifications of proteins (1993), CRC Press, Boca Raton